Home  /  Resource Library  /  First line high dose therapy and autologous blood stem cell transplantation in patients with primary central nervous system non-Hodgkin lymphomas – a single centre experience in 61 patients

First line high dose therapy and autologous blood stem cell transplantation in patients with primary central nervous system non-Hodgkin lymphomas – a single centre experience in 61 patients

Results of a study examining high does chemoimmunotherapy followed by autologous stem cell transplant for first line treatment of primary central nervous system lymphoma.